Cargando…

Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation

BACKGROUND: Hematopoietic stem cell transplantation is a curative treatment for several haematological malignancies. However, treatment related morbidity and mortality still is a limiting factor. Cyclophosphamide is widely used in condition regimens either in combination with other chemotherapy or w...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Serafi, Ibrahim, Abedi-Valugerdi, Manuchehr, Potácová, Zuzana, Afsharian, Parvaneh, Mattsson, Jonas, Moshfegh, Ali, Hassan, Moustapha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899295/ https://www.ncbi.nlm.nih.gov/pubmed/24466173 http://dx.doi.org/10.1371/journal.pone.0086619

Ejemplares similares

Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
por: El-Serafi, Ibrahim, et al.
Publicado: (2017)

Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation
por: El-Serafi, Ibrahim, et al.
Publicado: (2015)

COL-3-Induced Molecular and Ultrastructural Alterations in K562 Cells
por: Fares, Mona, et al.
Publicado: (2022)

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan‐Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
por: El‐Serafi, Ibrahim, et al.
Publicado: (2019)

The Role of Programmed Cell Death Ligand-1 (PD-L1/CD274) in the Development of Graft versus Host Disease
por: Al-Chaqmaqchi, Heevy, et al.
Publicado: (2013)

Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging
por: Asem, Heba, et al.
Publicado: (2016)

Expansion and Activation Kinetics of Immune Cells during Early Phase of GVHD in Mouse Model Based on Chemotherapy Conditioning
por: Sadeghi, Behnam, et al.
Publicado: (2010)

The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation
por: El-Serafi, Ibrahim, et al.
Publicado: (2018)

miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines
por: Ostadrahimi, Shiva, et al.
Publicado: (2018)

Correction: Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation
Publicado: (2014)

Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights
por: Shokoohian, Bahare, et al.
Publicado: (2021)

Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
por: Schoutrop, Esther, et al.
Publicado: (2023)

Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice
por: Sallam, Hatem, et al.
Publicado: (2013)

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
por: Anders, Carey K, et al.
Publicado: (2022)

Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia
por: Thakar, Monica S., et al.
Publicado: (2017)

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
por: Munchel, Ashley, et al.
Publicado: (2011)

Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase
por: Al-Hashmi, Sulaiman, et al.
Publicado: (2012)

Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
por: Navarro, Sandi L., et al.
Publicado: (2022)

Altered expression of 3´paralogus HOX A-D clusters in endometriosis disease: A case-control study
por: Golestan Jahromi, Masoumeh, et al.
Publicado: (2018)

The dose of cyclophosphamide for treating paraquat-induced rat lung injury
por: Choi, Jae-Sung, et al.
Publicado: (2013)

Differential Incorporation of β-actin as A Component of RNA Polymerase II into Regulatory Regions of Stemness/Differentiation Genes in Retinoic Acid-Induced Differentiated Human Embryonic Carcinoma Cells
por: Falahzadeh, Khadijeh, et al.
Publicado: (2016)

Is Post-Transplant Cyclophosphamide the New Methotrexate?
por: Mussetti, Alberto, et al.
Publicado: (2021)

Cytotoxic Effects of Tetracycline Analogues (Doxycycline, Minocycline and COL-3) in Acute Myeloid Leukemia HL-60 Cells
por: Song, Hairong, et al.
Publicado: (2014)

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Bahçecioğlu, Ömer Faruk, et al.
Publicado: (2021)

Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide
por: Trunk, Andrew D., et al.
Publicado: (2023)

Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide
por: Toyosaki, Masako, et al.
Publicado: (2018)

Novel +90G>A Intronic Polymorphism of CYP2D6
por: Modaresi-nejad, Monir, et al.
Publicado: (2015)

Metastasis of a transplantable mammary tumour in rats treated with cyclophosphamide and/or irradiation.
por: Moore, J. V., et al.
Publicado: (1977)

Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
por: Zhao, Chenchen, et al.
Publicado: (2022)

Low-dose cyclophosphamide-induced acute hepatotoxicity
por: Subramaniam, S. Ravih, et al.
Publicado: (2013)

High Dose Cyclophosphamide Treatment for Autoimmune Disorders
por: Brodsky, Robert A.
Publicado: (2002)

Low-Dose Cyclophosphamide Associated With Hyponatremia and Hepatotoxicity
por: DeChiara, James R, et al.
Publicado: (2023)

A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform
por: Mayumi, Hisanori
Publicado: (2021)

Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma
por: Delphine, Lebon, et al.
Publicado: (2023)

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
por: Bacigalupo, Andrea, et al.
Publicado: (2016)

Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis
por: Salas, Maria Queralt, et al.
Publicado: (2019)

Sonographic Findings in Partial Type of Trisomy 18
por: Niknejadi, Maryam, et al.
Publicado: (2014)

The Relationship between Functional Promoter Variants of Macrophage Migration Inhibitory Factor and Endometriosis
por: Chekini, Zahra, et al.
Publicado: (2021)

HOX cluster and their cofactors showed an altered expression pattern in eutopic and ectopic endometriosis tissues
por: Esfandiari, Fereshteh, et al.
Publicado: (2021)

Peyronie's Disease Treated with Oral Weekly Dexamethasone and Continuous Low-dose Cyclophosphamide
por: Gupta, Ramji, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_62vj6nauaf51m7980d5oc31lkn